Enlivex Therapeutics Newsroom

Enlivex Therapeutics Analyst Ratings

BenzingaDec 3 09:36 ET

Enlivex Therapeutics Is Maintained at Buy by D. Boral Capital

Dow JonesNov 14 17:12 ET

Enlivex Therapeutics Price Target Maintained With a $13.00/Share by D. Boral Capital

Dow JonesNov 14 17:12 ET

Enlivex Therapeutics Analyst Ratings

BenzingaNov 14 17:02 ET

H.C. Wainwright Maintains Enlivex Therapeutics(ENLV.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsSep 27 07:31 ET

H.C. Wainwright Maintains Enlivex Therapeutics(ENLV.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsSep 9 06:31 ET

Enlivex Therapeutics Price Target Announced at $13.00/Share by EF Hutton

Dow JonesAug 27 08:18 ET

Enlivex Therapeutics Analyst Ratings

BenzingaJun 11 06:17 ET

Enlivex Therapeutics Analyst Ratings

BenzingaApr 23 06:37 ET

Enlivex Therapeutics Analyst Ratings

BenzingaApr 12 06:44 ET

Enlivex Therapeutics Analyst Ratings

BenzingaSep 25, 2023 06:14 ET

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaAug 1, 2023 06:19 ET

Enlivex Therapeutics Analyst Ratings

BenzingaAug 1, 2023 06:18 ET

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaApr 24, 2023 06:37 ET

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaApr 5, 2023 06:50 ET

Enlivex Therapeutics Analyst Ratings

BenzingaFeb 24, 2023 06:28 ET

HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target

BenzingaFeb 24, 2023 06:20 ET

H.C. Wainwright Sticks to Its Buy Rating for Enlivex Therapeutics (ENLV)

TipRanksDec 1, 2022 06:55 ET

H.C. Wainwright Keeps Their Buy Rating on Enlivex Therapeutics (ENLV)

TipRanksSep 19, 2022 06:40 ET

H.C. Wainwright Reaffirms Their Buy Rating on Enlivex Therapeutics (ENLV)

TipRanksAug 30, 2022 06:20 ET